Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Company Data

Name Cardio Diagnostics Holdings Inc. - Warrant

Company Cardio Diagnostics Holdings, Inc.

Symbol CDIOW

Website https://cardiodiagnosticsinc.com

Primary Exchange

NASDAQ

ISIN US14159C1119

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Meeshanthini V. Dogan

Country United States of America

Currency USD

Employees 0,0 T

Address 400 N Aberdeen St, 60642 Chicago

ID Changes

Date	From	To
26.10.2022	MAAQW	CDIOW

Ticker Symbols

Name	Symbol
NASDAQ	CDIOW

More Shares

Investors who hold Cardio Diagnostics Holdings Inc. - Warrant also have the following shares in their portfolio:

CELGENE 13/43 Bond

US TREASURY 2045 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog